- Home
- CMND vs ATNF Comparison
CMND vs ATNF Comparison
Compare CMND & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMND
- ATNF
- Stock Information
- Founded
- CMND 2017
- ATNF 2016
- Country
- CMND Canada
- ATNF United States
- Employees
- CMND N/A
- ATNF N/A
- Industry
- CMND Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- CMND Health Care
- ATNF Health Care
- Exchange
- CMND Nasdaq
- ATNF Nasdaq
- Market Cap
- CMND 4.8M
- ATNF 5.0M
- IPO Year
- CMND N/A
- ATNF N/A
- Fundamental
- Price
- CMND $0.99
- ATNF $0.89
- Analyst Decision
- CMND
- ATNF
- Analyst Count
- CMND 0
- ATNF 0
- Target Price
- CMND N/A
- ATNF N/A
- AVG Volume (30 Days)
- CMND 2.2M
- ATNF 68.1K
- Earning Date
- CMND 06-12-2025
- ATNF 08-11-2025
- Dividend Yield
- CMND N/A
- ATNF N/A
- EPS Growth
- CMND N/A
- ATNF N/A
- EPS
- CMND N/A
- ATNF N/A
- Revenue
- CMND N/A
- ATNF N/A
- Revenue This Year
- CMND N/A
- ATNF N/A
- Revenue Next Year
- CMND N/A
- ATNF N/A
- P/E Ratio
- CMND N/A
- ATNF N/A
- Revenue Growth
- CMND N/A
- ATNF N/A
- 52 Week Low
- CMND $0.80
- ATNF $0.66
- 52 Week High
- CMND $2.30
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- CMND 55.23
- ATNF 48.21
- Support Level
- CMND $0.94
- ATNF $0.70
- Resistance Level
- CMND $1.05
- ATNF $0.93
- Average True Range (ATR)
- CMND 0.08
- ATNF 0.09
- MACD
- CMND 0.02
- ATNF 0.01
- Stochastic Oscillator
- CMND 34.38
- ATNF 58.79
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.